PulmoBioMed raises £1.4m for innovative lung test commercialization

PulmoBioMed – a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions – has raised £1.4m to help commercialize its technology.

Roivant’s CEO is a star, but even a blockbuster deal can’t escape biotech’s black hole

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did

October 23, 2023

Witnesses in OR Give Harrowing Account of Spleen Surgery Gone Wrong

The Florida Department of Health has suspended the license of Thomas Shaknovsky, DO, who removed a patient’s liver instead of his spleen, contributing to his

October 2, 2024

State-Regulated Psychedelics ‘On A Collision Course’ With FDA, Says Harvard Law Expert

A new article authored by renowned regulatory specialist Dr. Mason Marks, of the Project on Psychedelics Law and Regulation at Harvard Law School, highlights growing concern about the chasm between

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.